Home/Fzata/Elizabeth Smith, PhD, MBA
ES

Elizabeth Smith, PhD, MBA

Chief Business Officer

Fzata

Fzata Pipeline

DrugIndicationPhase
BioPYM Platform (Lead Program)Clostridioides difficile Infection (CDI)Pre-clinical